Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines.

Saved in:
Bibliographic Details
Title: Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines.
Authors: Russell CA; Department of Medical Microbiology & Infection Prevention, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Fouchier RAM; Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands., Ghaswalla P; Moderna, Inc., Cambridge, MA, USA., Park Y; Moderna, Inc., Cambridge, MA, USA., Vicic N; Moderna, Inc., Cambridge, MA, USA., Ananworanich J; Moderna, Inc., Cambridge, MA, USA., Nachbagauer R; Moderna, Inc., Cambridge, MA, USA., Rudin D; Moderna, Inc., Cambridge, MA, USA.
Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2336357. Date of Electronic Publication: 2024 Apr 15.
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38619079
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Russell+CA%22">Russell CA</searchLink>; Department of Medical Microbiology & Infection Prevention, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Fouchier+RAM%22">Fouchier RAM</searchLink>; Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Ghaswalla+P%22">Ghaswalla P</searchLink>; Moderna, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Park+Y%22">Park Y</searchLink>; Moderna, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Vicic+N%22">Vicic N</searchLink>; Moderna, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ananworanich+J%22">Ananworanich J</searchLink>; Moderna, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Nachbagauer+R%22">Nachbagauer R</searchLink>; Moderna, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Rudin+D%22">Rudin D</searchLink>; Moderna, Inc., Cambridge, MA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101572652%22">Human vaccines & immunotherapeutics</searchLink> [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2336357. <i>Date of Electronic Publication: </i>2024 Apr 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101572652 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2164-554X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221645515%22">21645515 </searchLink><i>NLM ISO Abbreviation: </i>Hum Vaccin Immunother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38619079
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/21645515.2024.2336357
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2336357
    Titles:
      – TitleFull: Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Russell CA
      – PersonEntity:
          Name:
            NameFull: Fouchier RAM
      – PersonEntity:
          Name:
            NameFull: Ghaswalla P
      – PersonEntity:
          Name:
            NameFull: Park Y
      – PersonEntity:
          Name:
            NameFull: Vicic N
      – PersonEntity:
          Name:
            NameFull: Ananworanich J
      – PersonEntity:
          Name:
            NameFull: Nachbagauer R
      – PersonEntity:
          Name:
            NameFull: Rudin D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 31
              M: 12
              Text: 2024 Dec 31
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2164-554X
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Human vaccines & immunotherapeutics
              Type: main
ResultId 1